APA (7th ed.) Citation

Burn, J., Gerdes, A., Macrae, F., Mecklin, J., Moeslein, G., Olschwang, S., . . . Bishop, D. T. (2011). Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. The Lancet (British edition), 378(9809), 2081-2087. https://doi.org/10.1016/S0140-6736(11)61049-0

Chicago Style (17th ed.) Citation

Burn, John, et al. "Long-term Effect of Aspirin on Cancer Risk in Carriers of Hereditary Colorectal Cancer: An Analysis from the CAPP2 Randomised Controlled Trial." The Lancet (British Edition) 378, no. 9809 (2011): 2081-2087. https://doi.org/10.1016/S0140-6736(11)61049-0.

MLA (9th ed.) Citation

Burn, John, et al. "Long-term Effect of Aspirin on Cancer Risk in Carriers of Hereditary Colorectal Cancer: An Analysis from the CAPP2 Randomised Controlled Trial." The Lancet (British Edition), vol. 378, no. 9809, 2011, pp. 2081-2087, https://doi.org/10.1016/S0140-6736(11)61049-0.